7 May 2001

Response to the GAVI debate by Aarti Kishuna, member of HAI Africa

In South Africa access to essential drugs and vaccines is truly about strengthening health systems, by focusing on four components, as spelt out in the WHO Medicines Strategy 2000 - 2003, i.e.:

a) rational selection
b) affordable prices
c) sustainable financing
d) reliable supply systems.

Rational selection
In the field of immunisation just taking rational selection into account the following problems hinder progress:

  • lack of reliable information. We really do not have effective and efficient health information systems established, let alone drug management information systems. This makes the rational selection of essential drugs a problem.
  • Once a medicine has been selected we also need to look at how it is being used - by prescribers, dispensers and the patients. In my province we recently changed from subcutaneous BCG to intra-dermal BCG. We already know of one case where a child, in a hospital, was given the intra-dermal form of the drug via the subcutaneous route. Whilst the administration of the vaccine did not cause the death of the child it certainly contributed to it. Why do I give you this example? I want to illustrate what happens when we do not integrate our systems when we implement programmes.

GAVI does allude to offering technical assistance, however my experience, and I am sure that of many other Africans, is that technical support often is dictated by the funding agency without actual consideration of what the health care system is trying to achieve. In the example I provided, the HRD section of my province trained trainers and nurses on how to administer the intra-dermal BCG. We have a system where nurses are rotated in the wards within the hospital. Obviously when the trained nurse was moved out of this ward, the person who replaced her had not received the training on the administration of the new product. She did what she was used to.

Now had we looked at the implementation of this vaccine from a systems point of view rather than another vertical programme, we would have had a proper human resource planning and training strategy in place which would ensure that all staff at whatever level of function received proper training and support at all times and the system should also be in a position to address gaps, where these exist.

When technical support is offered, it is offered for a particular programme or project. However people do not apply the principles learnt in the one programme to other programmes and just understand that this is what I must do for EPI. If the support is integrated into existing systems that address human resource development(HRD), rather than just HRD for this project it benefits far greater numbers as well as the system itself.

Affordable prices
SA pays high prices for its drugs, in general. I am not certain about whether our vaccines are more expensive than other countries.

Sustainable financing
It is this government's policy that there will be free services for pregnant women and children under 6. Therefore patients do not have to pay for vaccines. However we are already starting to see stock outs of many essential medicines due to limited finances at facility level. This may have to do with poor management but has a lot to do with the prices we pay. With GAVI new vaccines may be developed and introduced but at what cost? And will our existing policies of free services be able to cope with the increased costs? How will the initiative support our governments in adhering to their constitution of free health care when the drugs required become too expensive? Will the initiative provide technical support to ensure that there will be sustainability that is not dependent on donor funding or outside technical support?

My biggest issue with technical support is that it comes from outside our countries with ex-pats who often do not understand the local situations, or even if locals are used, they are paid salaries that our governments cannot afford so they will also leave once donor funding has dried up. When are locals going to actually possess the capacity required to develop, implement and actually manage programmes/projects? Whilst I agree that this is an issue for the government to deal with it is also very much influenced by donors and technical agencies. You get the distinct impression that our northern supporters view us as possessing really limited abilities, and whilst there may be evidence to support this - we require to be more creative in the manner we provide technical support.

Reliable supply systems
This issue is sometimes such a joke. We have been using polio vaccines which come with vaccine vial monitors ( a real treat when we donot have reliable cold chain maintenance). However we continue to dispense expired polio, i.e. the vvm's (vaccine vial monitors)have expired, even when we use private sector distribution systems.

In a country like SA with its many resources we still experience stock outs due to a multitude of reasons - the most important being poor management.

With regard to public private interactions, in my view:

  1. PPIs are bad for us when ownership of the process is undertaken by stakeholders not truly representative of our people and our governments, where civil society is not truly represented and where vested interests will continually dilute the picture in favour of the vested interest.
  2. Our government has a long way to go towards ensuring that access is addressed through strengthening existing or new supply systems, ensuring sustainable supply and rational selection and use. We should not just emphasis affordable prices when we do not take the responsibility of meeting the other aspects related to access, because when prices do become affordable (in someone's eyes) then are we (government) in a position to deliver?
  3. Integration of programmes is key, not just nationally but internationally as well. One of the biggest problems we experience from an operational point of view is that the international agencies, who often lead the technical support, sometimes do not appear to be working together. The final result will be countries receiving recommendations that are not mutually beneficial. For eg. with the introduction of IMCI and the EDP in SA, we found that IMCI guidelines and STGs produced through the DAP did not necessarily concur resulting in many fights at the local level.